Chart calendar Dyadic International, Inc.
Upcoming events on Dyadic International, Inc.
Past events on Dyadic International, Inc.
01/04/2024 | World Vaccine Congress |
29/03/2024 02:30 am | Q4 2023 Earnings Call |
29/03/2024 01:30 am | Q4 2023 Earnings Release |
22/03/2024 | Vaccine Innovation International Forum |
21/03/2024 | Future Food tech Innovation & Investment from Farm to Fork Conference |
18/03/2024 | BioEurope Spring Conference |
26/02/2024 | BIO CEO & Investor Conference |
01/02/2024 07:15 pm | Lytham Partners Investor Select Conference |
31/01/2024 | The Microcap Conference |
08/01/2024 04:45 am | BFC Global Healthcare BD and Investment Conference |
08/01/2024 | JPMorgan Healthcare Conference |
07/12/2023 | Benchmark Company Discovery Conference |
06/12/2023 01:30 am | Noble Capital Markets Emerging Growth Equity Conference |
16/11/2023 12:10 am | Vaccines Summit |
13/11/2023 | BARDA Industry Day |
09/11/2023 03:30 am | Q3 2023 Earnings Call |
09/11/2023 02:30 am | Q3 2023 Earnings Release |
07/11/2023 12:40 am | International Vaccines Research & Development Conference |
02/11/2023 | Cultured Meat Symposium |
18/10/2023 03:15 pm | World Vaccine Congress |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,68 1,70 -1.11% | 1,60 1,90 -15.69% | 2,40 8,00 -69.95% | 2,93 3,65 -19.72% | 2,90 3,05 -4.96% | 4,20 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -11,1 -8,90 -25.17% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -9,28 -9,40 1.25% | -10,0 -10,1 0.74% | -14,7 -12,4 -18.77% | -10,2 -10,1 -0.65% | -8,23 -8,05 -2.23% | -23,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,30 -8,50 2.38% | -9,29 -9,50 2.17% | -13,1 -10,7 -22.73% | -9,74 -9,65 -0.88% | -6,80 -6,60 -2.96% | -22,7 |
Net income Million USD | Released Forecast Spread | -8,31 -8,50 2.26% | -9,33 -9,50 1.84% | -13,1 -10,7 -22.73% | -9,74 -9,65 -0.88% | -6,80 -6,60 -2.96% | -22,7 |
EPS USD | Released Forecast Spread | -0,31 -0,31 0% | -0,34 -0,35 2.86% | -0,47 -0,38 -23.68% | -0,34 -0,34 0% | -0,24 -0,23 -4.35% | -0,66 |
Announcement Date | 30/03/20 | 30/03/21 | 29/03/22 | 29/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,31 0,80 -60.84% | 0,65 1,50 -56.77% | 0,66 2,40 -72.56% | 0,88 1,90 -53.71% | 0,74 1,45 -48.71% | 0,84 1,30 -35.6% | 0,40 1,20 -66.91% | 0,69 0,80 -14.18% | |
EBIT Million USD | Released Forecast Spread | -4,22 -1,95 -116.19% | -2,74 -3,90 29.62% | -3,32 -2,30 -44.26% | -1,86 -2,75 32.24% | -2,24 -2,15 -4.17% | -2,29 -1,50 -52.7% | -1,72 -1,70 -1.18% | -2,17 -1,95 -11.22% | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,21 -1,85 -127.78% | -2,49 -3,90 36.11% | -3,29 -2,15 -52.93% | -1,81 -2,65 31.73% | -2,15 -2,05 -4.7% | -2,15 -1,40 -53.78% | -1,61 -1,65 2.17% | -2,07 -1,90 -9.04% | |
Net income Million USD | Released Forecast Spread | -4,21 -1,85 -127.78% | -2,49 -3,90 36.11% | -3,29 -2,15 -52.93% | -1,81 -2,65 31.73% | -2,15 -2,05 -4.7% | -0,96 | -2,15 -1,40 -53.78% | -1,61 -1,65 2.17% | -2,07 -1,90 -9.04% |
EPS USD | Released Forecast Spread | -0,15 -0,07 -130.77% | -0,09 -0,14 35.71% | -0,12 -0,08 -60% | -0,06 -0,10 36.84% | -0,07 -0,07 0% | -0,03 | -0,07 -0,05 -40% | -0,06 -0,06 0% | -0,08 -0,07 -23.08% |
Announcement Date | 29/03/22 | 12/05/22 | 10/08/22 | 10/11/22 | 29/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 28/03/24 |
Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |